摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(Cyclopentyloxy)-7-methoxychroman-4-one oxime | 1001061-72-8

中文名称
——
中文别名
——
英文名称
8-(Cyclopentyloxy)-7-methoxychroman-4-one oxime
英文别名
N-(8-cyclopentyloxy-7-methoxy-2,3-dihydrochromen-4-ylidene)hydroxylamine
8-(Cyclopentyloxy)-7-methoxychroman-4-one oxime化学式
CAS
1001061-72-8
化学式
C15H19NO4
mdl
——
分子量
277.32
InChiKey
RJEMIJSZUPNFIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    60.3
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    8-(Cyclopentyloxy)-7-methoxychroman-4-one oxime 在 palladium 10% on activated carbon 、 氢气 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 84.0h, 生成 8-(Cyclopentyloxy)-7-methoxychroman-4-amine
    参考文献:
    名称:
    Water-soluble PDE4 inhibitors for the treatment of dry eye
    摘要:
    PDE4 inhibitors have the potential to alleviate the symptoms and underlying inflammation associated with dry eye. Disclosed herein is the development of a novel series of water-soluble PDE4 inhibitors. Our studies led to the discovery of coumarin 18, which is effective in a rabbit model of dry eye and a tear secretion test in rats. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.03.023
  • 作为产物:
    参考文献:
    名称:
    Water-soluble PDE4 inhibitors for the treatment of dry eye
    摘要:
    PDE4 inhibitors have the potential to alleviate the symptoms and underlying inflammation associated with dry eye. Disclosed herein is the development of a novel series of water-soluble PDE4 inhibitors. Our studies led to the discovery of coumarin 18, which is effective in a rabbit model of dry eye and a tear secretion test in rats. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.03.023
点击查看最新优质反应信息

文献信息

  • BICYCLIC HETEROARYL INHIBITORS OF PDE4
    申请人:Govek Steven P.
    公开号:US20090291950A1
    公开(公告)日:2009-11-26
    The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PD E4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
    本发明涉及化合物和方法,可用作磷酸二酯酶4(PDE4)的抑制剂,用于治疗或预防炎症性疾病和其他涉及细胞因子和促炎介质平升高的疾病。
查看更多